Buy Crypto Markets Spot FuturesGOLD Earn Event Centre

Orchestra BioMed Holdings, Inc. (OBIO)

NASDAQ

$4.58

$+0.10

(+2.13%)

Orchestra BioMed Holdings, Inc. (OBIO) Live Price Chart

Page last updated: 2026-04-17 20:11:00

Key Market Data

Market Cap	$267.91M
Open	$4.53
High	$23.39
Low	$2.20
Previous Close	$4.47
Price Change	$+0.10
Percentage Change	+2.13%
Volume	121K

Orchestra BioMed Holdings, Inc. (OBIO) Stock Price Today

Orchestra BioMed Holdings, Inc. (OBIO) is currently trading at $4.58 as of 2026-04-17 20:11:00, reflecting a +2.13% move ($+0.10) from the previous close.

In the short term, the stock has returned -1.34% over the past four weeks. Over the last 12 months, Orchestra BioMed Holdings, Inc. has recorded a +61.20% price change, indicating a Strong performance relative to the broader market.

Orchestra BioMed Holdings, Inc. (OBIO) 7-Day Stock Price Changes

Over the past seven days, Orchestra BioMed Holdings, Inc. has traded within a short-term range shaped by market sentiment in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. During this period, the stock moved from its previous closing price of $4.12 to the latest recorded price of $4.58, reflecting an intraday change of +2.13%. Daily movements highlight shifts in trading volume (120,756), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, OBIO has delivered a -1.34% return over the past month and a +61.20% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.

How to Buy Orchestra BioMed Holdings, Inc. (OBIO)

You can buy and trade OBIO on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for OBIO and Execute Your Trade

Open the trading page, enter OBIO in the search bar, select the amount of OBIO you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Orchestra BioMed Holdings, Inc. (OBIO)?

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Orchestra BioMed Holdings, Inc. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	86
Sector	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Website	https://www.orchestrabiomed.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Orchestra BioMed Holdings, Inc.?

The latest trading price for Orchestra BioMed Holdings, Inc. (Common Stock) is $ 4.58, compared with a previous closing price of $ 4.47. That means the stock has moved +2.13% so far today. Intraday price updates and recent trading activity for OBIO can be tracked on the live chart and quote section on this page.

2.Is Orchestra BioMed Holdings, Inc. stock going up or down?

Looking at recent performances, OBIO has returned -1.34% over the past month, +17.69% over the last six months and +61.20% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Strong price momentum for Orchestra BioMed Holdings, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does OBIO currently sit relative to its 52-week high and low?

In the most recent 52-week period, Orchestra BioMed Holdings, Inc. has traded between a low of $ 2.20 and a high of $ 5.42. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether OBIO is currently nearer the top or the bottom of its one-year trading band.

4.How is Orchestra BioMed Holdings, Inc. classified by sector and industry?

Orchestra BioMed Holdings, Inc. is classified in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. In practice, this means Orchestra BioMed Holdings, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing OBIO’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector could influence Orchestra BioMed Holdings, Inc.’s performance.

5.Where is Orchestra BioMed Holdings, Inc. listed and how large is it by market value?

Orchestra BioMed Holdings, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 267.91M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Orchestra BioMed Holdings, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does OBIO's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.90 summarises how much profit Orchestra BioMed Holdings, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Orchestra BioMed Holdings, Inc.'s financial performance over time?

To follow Orchestra BioMed Holdings, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how OBIO is performing and how the market is responding.

8.When is Orchestra BioMed Holdings, Inc. expected to report earnings?

Orchestra BioMed Holdings, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for OBIO, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Orchestra BioMed Holdings, Inc.'s earnings reports?

Orchestra BioMed Holdings, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether OBIO is meeting, beating or missing expectations.

10.How can I stay informed about Orchestra BioMed Holdings, Inc.'s results and guidance?

You can stay up to date on Orchestra BioMed Holdings, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for OBIO on this page helps you see how new information is being reflected in the stock.

11.Does Orchestra BioMed Holdings, Inc. pay a regular cash dividend to its shareholders?

Orchestra BioMed Holdings, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor OBIO's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for OBIO?

Based on the latest earnings data, OBIO has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Orchestra BioMed Holdings, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Orchestra BioMed Holdings, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Orchestra BioMed Holdings, Inc.?

Orchestra BioMed Holdings, Inc. is a publicly traded company in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry within the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is OBIO valued in terms of P/E ratio and EPS?

Orchestra BioMed Holdings, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.90. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Orchestra BioMed Holdings, Inc.'s earnings. Comparing OBIO's P/E and EPS to those of other SURGICAL & MEDICAL INSTRUMENTS & APPARATUS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

Mawson Infrastructure Group Inc.

MIGI

Canopy Growth Corporation

CGC

The Kraft Heinz Company

KHC

Top Gainers

Browse today's leading gainers in the US stock market

Energy Focus, Inc.

EFOI

Forum Markets, Incorporated

FRMM

Beasley Broadcasting Group Inc.

BBGI

Psyence Biomedical Ltd

PBM

Blaize Holdings, Inc.

BZAI

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

OBIO-to-USD Calculator

Amount

OBIO

USD

1 OBIO = 4.578 USD